Sadoff Investment Management Lowers stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Sadoff Investment Management reduced its stake in Johnson & Johnson by 1.2% during the most recent quarter end. The investment management company now holds a total of 6,426 shares of Johnson & Johnson which is valued at $766,236 after selling 78 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Johnson & Johnson makes up approximately 0.08% of Sadoff Investment Management’s portfolio.

Other Hedge Funds, Including , Stokes Hubbell Capital Management boosted its stake in JNJ in the latest quarter, The investment management firm added 269 additional shares and now holds a total of 89,666 shares of Johnson & Johnson which is valued at $10,691,774. Johnson & Johnson makes up approx 4.45% of Stokes Hubbell Capital Management’s portfolio.Franklin Street Advisors Inc Nc boosted its stake in JNJ in the latest quarter, The investment management firm added 19,947 additional shares and now holds a total of 84,373 shares of Johnson & Johnson which is valued at $10,055,574. Johnson & Johnson makes up approx 1.85% of Franklin Street Advisors Inc Nc’s portfolio.New England Research Management boosted its stake in JNJ in the latest quarter, The investment management firm added 5,063 additional shares and now holds a total of 30,343 shares of Johnson & Johnson which is valued at $3,616,279. Johnson & Johnson makes up approx 3.05% of New England Research Management’s portfolio.Telemus Capital reduced its stake in JNJ by selling 425 shares or 1.22% in the most recent quarter. The Hedge Fund company now holds 34,332 shares of JNJ which is valued at $4,091,688. Johnson & Johnson makes up approx 0.46% of Telemus Capital’s portfolio.Cullinan Associates Inc reduced its stake in JNJ by selling 5,237 shares or 3.33% in the most recent quarter. The Hedge Fund company now holds 152,070 shares of JNJ which is valued at $18,123,703. Johnson & Johnson makes up approx 1.56% of Cullinan Associates Inc’s portfolio.

Johnson & Johnson opened for trading at $119.17 and hit $119.565 on the upside on Friday, eventually ending the session at $119.24, with a gain of 0.41% or 0.49 points. The heightened volatility saw the trading volume jump to 47,99,292 shares. Company has a market cap of $326,226 M.

On the company’s financial health, Johnson & Johnson reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.68. The company had revenue of $18482.00 million for the quarter, compared to analysts expectations of $17985.80 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.

Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by UBS on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 137 from a previous price target of $126 .Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 133 from a previous price target of $125 .

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.